Search

Your search keyword '"Yakushijin Y"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Yakushijin Y" Remove constraint Author: "Yakushijin Y"
128 results on '"Yakushijin Y"'

Search Results

5. PS1259 LONG-TERM FOLLOW-UP OF JCOG0406 STUDY: INTENSIVE IMMUNOCHEMOTHERAPY (R-HIGH CHOP/CHASER) FOLLOWED BY HIGH-DOSE CHEMOTHERAPY (LEED) WITH AUTO-PBSCT IN UNTREATED MANTLE CELL LYMPHOMA

9. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

16. Distinguishing Axillary Lymphadenopathy after COVID-19 Vaccination from Malignant Lymphadenopathy.

17. Treatments and prognostic factors for bone and soft tissue sarcoma in non-urban areas in Japan.

18. A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.

19. Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406.

20. [Development and Verification of an irAEs Self-Reported Interview System(ISRIS)].

21. Frequency and component analysis of contaminants generated in preparation of anticancer agents using closed system drug transfer devices (CSTDs).

22. Treatment and prognosis of patients with both cancer and impaired decision-patient with both cancer and dementia making as a symptom of dementia.

23. A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial.

24. Pneumocystis jirovecii Pneumonia Prophylaxis for Cancer Patients during Chemotherapy.

25. The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma.

26. R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.

27. [Assessment of Chemotherapy-Induced Adverse Events Using a Sharing System of Patient-Reported Information via a Touch Panel].

28. Liquid Formulation of Gemcitabine Increases Venous Pain in Patients With Cancer: A Retrospective Study.

29. Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis.

30. Effect of pelvic belt on the perception of difficulty and muscle activity during active straight leg raising test in pain-free subjects.

31. Patient-related Risk Factors for Nausea and Vomiting with Standard Antiemetics in Patients with Breast Cancer Receiving Anthracycline-based Chemotherapy: A Retrospective Observational Study.

32. Olanzapine plus aprepitant, palonosetron, and dexamethasone for nausea and vomiting in patients with breast cancer receiving anthracycline: A retrospective study.

33. An unusual, CD4 and CD8 dual-positive, CD25 negative, tumor cell phenotype in a patient with adult T-cell leukemia/lymphoma.

34. Development and validity testing of the revised diabetes self-care inventory for children and adolescents.

35. R-High-CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY.

36. Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics.

37. Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain.

38. A study on the colonization of Pneumocystis jirovecii among outpatients during cancer chemotherapy and among healthy smokers.

39. Antiemetic Effectiveness and Cost-Saving of Aprepitant plus Granisetron Is Superior to Palonosetron in Gastrointestinal Cancer Patients Who Received Moderately Emetogenic Chemotherapy.

40. Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study.

41. Vancomycin-induced Immune Thrombocytopenia Proven by the Detection of Vancomycin-dependent Anti-platelet Antibody with Flow Cytometry.

42. [Risk Factors for Oxaliplatin-Induced Phlebitis and Venous Pain, and Evaluation of the Preventive Effect of Preheating with a Hot Compress for Administration of Oxaliplatin].

43. Decreased Expression of Innate Immunity-Related Genes in Peripheral Blood Mononuclear Cells from Patients with IgG4-Related Disease.

44. Dramatic and prompt efficacy of Helicobacter pylori eradication in the treatment of severe refractory iron deficiency anemia in adults.

45. [Awareness about medical expenses and certifications of eligibility for limited health insurance payments for chemotherapy among clinicians at the Ehime Cancer Care Network Priority Hospitals (Ehime Cancer Kyoten Hospitals)].

46. Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP.

47. Acquisition of MYD88 L265P mutation during treatment of diffuse large B cell lymphoma of the parotid gland.

48. [Preventive trial of preheating administration of oxaliplatin-diluted solution in combination with a hot compress for oxaliplatin-induced venous pain].

50. Concurrent administration of rituximab and CHOP chemotherapeutic agents for outpatients with CD20-positive lymphoma.

Catalog

Books, media, physical & digital resources